ShareValue scores for 688189.SHG: Valuation 43, Quality 39, Growth 21, Health 52.

688189.SHG
SSE

Hunan Nucien Pharmaceutical Co Ltd

CN¥6.71(+3.39%)
Loading chart...
Sentiment

Verdicts

Rating

Trap Risk

Return

4% to 15%
Valuation
43
Fair Value
Price vs Value
Quality
39
Weak
Business Strength
Growth
21
Weak
Revenue & Earnings
Health
52
Moderate
Financial Stability
Momentum
47
Neutral
Price Trend

Company Details

About

Hunan Nucien Pharmaceutical Co., Ltd., a pharmaceutical company, engages in the research and development, production, and sale of chemical drugs in China. The company also focuses on the research, development, production, and sales of antiviral drugs, including influenza and infectious disease prevention and treatment drugs, as well as medicines for anti-influenza, malignant tumors, cardiovascular, antibiotics, antipyretics, pain relief, diabetes, analgesic, cerebrovascular, respiratory, and other pharmaceutical fields. Hunan Nucien Pharmaceutical Co., Ltd. was founded in 2006 and is based in Guangzhou, China.

Score Analysis

AI Investment Thesis

Data as of:Aug 7, 2026
|
Last calculated:Aug 7, 2026